Platelet microparticles contain active caspase 3

During storage, platelets undergo processes resembling apoptosis, including microparticle release, aminophospholipid exposure, and procaspase 3 processing. Recently, we showed that microparticles from endothelial cells contain caspase 3, one of the executioner enzymes of apoptosis. In this study we determined whether platelet-derived microparticles (PMP) contain caspase 3 in vitro (stored platelet concentrate) and ex vivo (plasma from healthy humans). In addition, we studied the underlying mechanism of caspase 3 formation in PMP, and the ability of such PMP to induce apoptosis in human macrophages (THP-1 cells). The presence of caspase 3 (antigen) was studied by Western blot and flowcytometry, and activity was determined by Ac-DEVD-pNA and ROCK I cleavage. In vitro, PMP numbers increased during storage. From day one onwards, PMP contained procaspase 3, whereas caspase 3 (antigen and activity) was detectable after 5–7 days of storage. PMP contained caspase 9 but not caspase 8, and the time course of caspase 9 formation paralleled procaspase 3 disappearance and caspase 3 appearance. In addition, PMP in human plasma also contained detectable quantities of caspase 3. Incubation of THP-1 cells with PMP induced apoptosis. Taken together, PMP contain caspase 3 in vitro and ex vivo. Our data implicate that procaspase 3 is likely to be processed by caspase 9 in PMP during storage. PMP induce apoptosis of human macrophages, but whether this induction is due to the transfer of caspase 3 remains to be determined.

[1]  K. Suckling,et al.  Oxidation of chylomicron remnant-like particles inhibits their uptake by THP-1 macrophages by apolipoprotein E-dependent processes , 2007, Biochimica et biophysica acta.

[2]  G. Lip,et al.  Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation , 2005, Platelets.

[3]  R. Nieuwland,et al.  Cell‐derived microparticles contain caspase 3 in vitro and in vivo , 2005, Journal of thrombosis and haemostasis : JTH.

[4]  M. Matsumura,et al.  Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. , 2005, Diabetes research and clinical practice.

[5]  M. Wadhwa,et al.  In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools , 2005, Vox sanguinis.

[6]  G. Lip,et al.  Platelet microparticles and soluble P selectin in peripheral artery disease: Relationship to extent of disease and platelet activation markers , 2005, Annals of medicine.

[7]  P. Tawa,et al.  Catalytic activity of caspase-3 is required for its degradation: stabilization of the active complex by synthetic inhibitors , 2004, Cell Death and Differentiation.

[8]  M. Dikshit,et al.  Platelet storage under in vitro condition is associated with calcium-dependent apoptosis-like lesions and novel reorganization in platelet cytoskeleton. , 2004, Archives of biochemistry and biophysics.

[9]  G. Raposo,et al.  Lipid raft-associated protein sorting in exosomes. , 2003, Blood.

[10]  D. Kuter,et al.  Apoptotic markers are increased in platelets stored at 37°C , 2003 .

[11]  P. Perrotta,et al.  Apoptotic activity in stored human platelets , 2003, Transfusion.

[12]  Richard A. Preston,et al.  Effects of Severe Hypertension on Endothelial and Platelet Microparticles , 2003, Hypertension.

[13]  K. Tsuchiya,et al.  Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. , 2002, Kidney international.

[14]  F. Breedveld,et al.  Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. , 2002, Arthritis and rheumatism.

[15]  L. Corcos,et al.  Early increase in DcR2 expression and late activation of caspases in the platelet storage lesion , 2001, Leukemia.

[16]  F. Picard,et al.  Flow Cytometry Detection of Platelet Procoagulant Activity and Microparticles in Patients with Unstable Angina Treated by Percutaneous Coronary Angioplasty and Stent Implantation , 2001, Thrombosis and Haemostasis.

[17]  J. Bertoglio,et al.  Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing , 2001, Nature Cell Biology.

[18]  D. Kuter,et al.  The mechanism of apoptosis in human platelets during storage , 2000, Transfusion.

[19]  J. Savill,et al.  Constitutive Death of Platelets Leading to Scavenger Receptor-mediated Phagocytosis , 2000, The Journal of Biological Chemistry.

[20]  R. Westendorp,et al.  Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. , 2000, Blood.

[21]  D. Green,et al.  Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. , 1999, Blood.

[22]  J. Freedman,et al.  Flow cytometric analysis of platelet function in stored platelet concentrates. , 1999, Transfusion science.

[23]  S. Orrenius,et al.  Alterations in Bcl‐2/Bax protein levels in platelets form part of an ionomycin‐induced process that resembles apoptosis , 1997, British journal of haematology.

[24]  R. Holcombe,et al.  Quantitation of CD62, soluble CD62, and lysosome‐associated membrane proteins 1 and 2 for evaluation of the quality of stored platelet concentrates , 1995, Transfusion.

[25]  S. Orton,et al.  Vesiculation of platelets during in vitro aging. , 1991, Blood.

[26]  Link,et al.  UvA-DARE ( Digital Academic Repository ) Endothelial cell-derived microparticles , 2007 .

[27]  D. Kuter,et al.  Apoptotic markers are increased in platelets stored at 37 degrees C. , 2003, Transfusion.

[28]  E. Remold-O’Donnell,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Role of Caspase in a Subset of Human Platelet Activation Responses , 1999 .